DRIO
Price
$3.46
Change
-$0.22 (-5.98%)
Updated
Oct 22, 04:58 PM (EDT)
Capitalization
36.06M
21 days until earnings call
Intraday BUY SELL Signals
ILMN
Price
$269.34
Change
-$13.52 (-4.78%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
42.71B
7 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DRIO vs ILMN

DRIO vs ILMN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DRIO vs. ILMN commentary
Oct 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRIO is a Hold and ILMN is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for DRIO with price predictions
Oct 21, 2026

DRIO's RSI Oscillator sits in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +4.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where DRIO advanced for three days, in 177 of 235 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

DRIO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 25, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DRIO as a result. In 86 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for DRIO turned negative on September 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 40 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.

DRIO moved below its 50-day moving average on September 21, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DRIO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for DRIO entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.655) is normal, around the industry mean (4.100). P/E Ratio (-0.247) is within average values for comparable stocks, (13.263). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (2.386) is also within normal values, averaging (6.065).

The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. DRIO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DRIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.

A.I.Advisor
a Summary for ILMN with price predictions
Oct 21, 2026

Aroon Indicator for ILMN shows an upward move is likely

ILMN's Aroon Indicator triggered a bullish signal on October 15, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 214 similar instances where the Aroon Indicator showed a similar pattern. In 187 of the 214 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 58 cases where ILMN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on ILMN as a result. In 73 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.

Following a +7.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where ILMN advanced for three days, in 201 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

Bearish Trend Analysis

The 10-day RSI Indicator for ILMN moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 17 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 65%.

The Moving Average Convergence Divergence Histogram (MACD) for ILMN turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In 39 of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ILMN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

ILMN broke above its upper Bollinger Band on September 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 1 (best 1 - 100 worst), indicating outstanding price growth. ILMN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.050) is normal, around the industry mean (64.450). P/E Ratio (52.479) is within average values for comparable stocks, (2.086). Projected Growth (PEG Ratio) (3.355) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (7.843) is also within normal values, averaging (9.775).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ILMN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

FUNDAMENTALS RATINGS
DRIO vs ILMN: Fundamental Ratings
DRIO
ILMN
OUTLOOK RATING
1..100
5190
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9831
PRICE GROWTH RATING
1..100
921
P/E GROWTH RATING
1..100
102
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DRIO's Valuation (46) in the Medical Specialties industry is somewhat better than the same rating for ILMN (86) in the Biotechnology industry. This means that DRIO’s stock grew somewhat faster than ILMN’s over the last 12 months.

DRIO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ILMN (100) in the Biotechnology industry. This means that DRIO’s stock grew similarly to ILMN’s over the last 12 months.

ILMN's SMR Rating (31) in the Biotechnology industry is significantly better than the same rating for DRIO (98) in the Medical Specialties industry. This means that ILMN’s stock grew significantly faster than DRIO’s over the last 12 months.

ILMN's Price Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for DRIO (92) in the Medical Specialties industry. This means that ILMN’s stock grew significantly faster than DRIO’s over the last 12 months.

ILMN's P/E Growth Rating (2) in the Biotechnology industry is in the same range as DRIO (10) in the Medical Specialties industry. This means that ILMN’s stock grew similarly to DRIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DRIOILMN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 16 days ago
75%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 7 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
87%
COMPARISON
Comparison
Oct 22, 2026
Stock price -- (DRIO: $3.68 vs. ILMN: $282.86)
Brand notoriety: DRIO: Not notable vs. ILMN: Notable
DRIO represents the Services to the Health Industry, while ILMN is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DRIO: 1197% vs. ILMN: 64%
Market capitalization -- DRIO: $36.06M vs. ILMN: $42.71B
DRIO [@Services to the Health Industry] is valued at $36.06M. ILMN’s [@Medical Specialties] market capitalization is $42.71B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $708 to $51.9B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Services to the Health Industry] industry is $3.19B. The average market capitalization across the [@Medical Specialties] industry is $20.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRIO’s FA Score shows that 1 FA rating(s) are green while ILMN’s FA Score has 3 green FA rating(s).

  • DRIO’s FA Score: 1 green, 4 red.
  • ILMN’s FA Score: 3 green, 2 red.
According to our system of comparison, ILMN is a better buy in the long-term than DRIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRIO’s TA Score shows that 4 TA indicator(s) are bullish while ILMN’s TA Score has 4 bullish TA indicator(s).

  • DRIO’s TA Score: 4 bullish, 5 bearish.
  • ILMN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ILMN is a better buy in the short-term than DRIO.

Price Growth

DRIO (@Services to the Health Industry) experienced а -32.48% price change this week, while ILMN (@Medical Specialties) price change was +4.08% for the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.65%. For the same industry, the average monthly price growth was -3.81%, and the average quarterly price growth was +15.91%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.15%. For the same industry, the average monthly price growth was -6.50%, and the average quarterly price growth was +42.74%.

Reported Earning Dates

DRIO is expected to report earnings on Nov 12, 2026.

ILMN is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Services to the Health Industry (-1.65% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

@Medical Specialties (-3.15% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
DRIO
Daily Signal:
Gain/Loss:
ILMN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

DRIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRIO has been loosely correlated with TWST. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if DRIO jumps, then TWST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRIO
1D Price
Change %
DRIO100%
-9.80%
TWST - DRIO
34%
Loosely correlated
+4.51%
VCYT - DRIO
28%
Poorly correlated
+3.19%
XWEL - DRIO
28%
Poorly correlated
+7.32%
BNGO - DRIO
28%
Poorly correlated
+0.40%
ILMN - DRIO
27%
Poorly correlated
+5.57%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNA10.010.15
+1.52%
Ginkgo Bioworks Holdings
KAI265.600.79
+0.30%
Kadant
RVSB6.02N/A
N/A
Riverview Bancorp
FIS36.42-0.01
-0.03%
Fidelity National Information Services
WAFU1.48-0.03
-1.99%
Wah Fu Education & Technology Group Ltd.